Mauritskliniek intends to join Corius

Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. Corius is the largest network of dermatology and phlebology practices in Germany and Switzerland.

By acquiring Mauritskliniek, Corius geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of  Corius.

Mauritskliniek intends to join Corius in the third quarter of 2022, after potential approval of the  Nederlandse Zorgautoriteit (NZa).

About Corius

Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. Corius offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. Corius has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de

About Mauritskliniek

Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.6/10 points, according zorgkaartnederland.nl. www.maurtiskliniek.nl

About Holland Capital

Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.

Yenlo acquires Datacon to join forces in integration landscape

Yenlo acquires Datacon to join forces in integration landscapeThe Datacon acquisition opens both vertical and horizontal growth possibilities for both system integrators. Amsterdam, October 18th , 2021 – Our portfolio company Yenlo acquires Datacon in a move that sees...

40 years of Holland Capital: enterprising and ambitious

40 years of Holland Capital: enterprising and ambitious Amsterdam, September 30, 2021 – 40 years ago, private equity firm Holland Capital started preaching the “Gospel of private equity”. Currently, it operates with a distinct investment strategy, focusing on...

Xilloc raises growth financing from Holland Capital

Xilloc raises growth financing from Holland Capital Geleen/Amsterdam, July 2nd 2021 - Xilloc, a leading innovator and producer of medical implants and devices, has raised growth finance for its international expansion and product development from Holland Capital....

Yes We Can Healthcare Group joins forces with Holland Capital

Yes We Can Healthcare Group joins forces with Holland Capital Hilvarenbeek / Amsterdam, 1st of July 2021 – Holland Capital joins forces with Yes We Can Healthcare Group (YWCHG), a mental healthcare clinic for young people between 13 and 23 with addictions and...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11

 

Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01